Lipoic Acid for Progressive Multiple Sclerosis (MS)
Clinical trial NCT03161028 · COMPLETED
Trial details
- NCT number
- NCT03161028
- Sponsor
- VA Office of Research and Development
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-17
- Primary completion
- 2023-12-31
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.